Characterization of blaOXA-143 variants in acinetobacter baumannii and acinetobacter pittii

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 5, 2014, Pages 2704-2708

  ZanDer, Esther ^a   Bonnin, Rémy A ^b   Seifert, Harald ^a   Higginsa, Paul G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; CARBAPENEM; CARBAPENEM DERIVATIVE; CARBAPENEMASE; COMPLEMENTARY DNA; IMIPENEM; MEROPENEM; OXACILLINASE 143; OXACILLINASE 182; OXACILLINASE 231; OXACILLINASE 253; OXACILLINASE 255; TICARCILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; OXACILLINASE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; MICROBIAL SENSITIVITY TESTS;

EID: 84898619560     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02618-13     Document Type: Article

References (31)

1. Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus- Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162:393-404. http://dx.doi.org/10.1016/j.resmic.2011.02.006.
2. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951. http://dx.doi.org/10.1038/nrmicro1789.
3. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L. 2012. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One 7:e46984. http://dx.doi.org/10.1371/journal.pone.0046984.
4. Visca P, Seifert H, Towner KJ. 2011. Acinetobacter infection- an emerging threat to human health. IUBMB Life 63:1048-1054. http://dx.doi.org/10.1002/iub. 534.
5. Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, Wang Y, Liu H, Zheng D, Xia Y, Yu R, Han X, Jiang G, Zhou Y, Zhou W, Hu X, Liang L, Han L. 2012. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin. Microbiol. Infect. 18:E506-E513. http://dx.doi.org/10.1111/1469-0691.12035.
6. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
7. Schleicher X, Higgins PG, Wisplinghoff H, Korber-Irrgang B, Kresken M, Seifert H. 2013. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005- 2009). Clin. Microbiol. Infect. 19:737-742. http://dx.doi.org/10.1111/1469-0691.12026.
8. Higgins PG, Perez-Llarena FJ, Zander E, Fernandez A, Bou G, Seifert H. 2013. OXA-235, a novel class D-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 57:2121-2126. http://dx.doi.org/10.1128/AAC.02413-12.
9. Evans BA, Hamouda A, Amyes SG. 2013. The rise of carbapenemresistant Acinetobacter baumannii. Curr. Pharm. Des. 19:223-238. http://dx.doi.org/10. 2174/138161213804070285.
10. Boo TW, Walsh F, Crowley B. 2006. First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic. J. Antimicrob. Chemother. 58:1101-1102. http://dx.doi.org/10.1093/jac/dkl345.
11. Evans BA, Hamouda A, Towner KJ, Amyes SG. 2010. Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3. J. Antimicrob. Chemother. 65:1586-1588. http://dx.doi.org/10.1093/jac/dkq180.
12. Bonnin RA, Docobo-Pérez F, Poirel L, Villegas M-V, Nordmann P. 2014. Emergence of OXA-72-producing Acinetobacter pittii clinical isolates. Int. J. Antimicrob. Agents 43:195-196. http://dx.doi.org/10.1016/j.ijantimicag.2013. 10.005.
13. Wang H, Guo P, Sun H, Yang Q, Chen M, Xu Y, Zhu Y. 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51:4022-4028. http://dx.doi.org/10.1128/AAC.01259-06.
14. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D-lactamases. Antimicrob. Agents Chemother. 54:24- 38. http://dx.doi.org/10.1128/AAC.01512-08.
15. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. 2009. OXA-143, a novel carbapenem-hydrolyzing class D-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:5035-5038. http://dx.doi.org/10.1128/AAC.00856- 09.
16. Higgins PG, Lehmann M, Seifert H. 2010. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 35:305. http://dx.doi.org/10.1016/j.ijantimicag.2009.10.014.
17. Mostachio AK, Levin AS, Rizek C, Rossi F, Zerbini J, Costa SF. 2012. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. Int. J. Antimicrob. Agents 39:396-401. http://dx.doi.org/10.1016/j.ijantimicag.2012.01.021.
18. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004.
19. Healy M, Huong J, Bittner T, Lising M, Frye S, Raza S, Schrock R, Manry J, Renwick A, Nieto R, Woods C, Versalovic J, Lupski Jr. 2005. Microbial DNA typing by automated repetitive-sequence-based PCR. J. Clin. Microbiol. 43:199-207. http://dx.doi.org/10.1128/JCM.43.1.199-207.2005.
20. Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:4174-4179. http://dx.doi.org/10.1128/AAC.49.10.4174-4179.2005.
21. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Gottig S, Hunfeld KP, Seifert H, Witte W, Higgins PG. 2011. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J. Antimicrob. Chemother. 66:1998-2001. http://dx.doi.org/10.1093/jac/dkr256.
22. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54: 4168-4177. http://dx.doi.org/10.1128/AAC.00542-10.
23. Choi KH, Kumar A, Schweizer HP. 2006. A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J. Microbiol. Methods 64:391-397. http://dx.doi.org/10.1016/j.mimet.2005.06.001.
24. Higgins PG, Dammhayn C, Hackel M, Seifert H. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65:233-238. http://dx.doi.org/10.1093/jac/dkp428.
25. Gionco B, Pelayo JS, Venancio EJ, Cayo R, Gales AC, Carrara-Marroni FE. 2012. Detection of OXA-231, a new variant of blaOXA-143, in Acinetobacter baumannii from Brazil: a case report. J. Antimicrob. Chemother. 67:2531-2532. http://dx.doi.org/10.1093/jac/dks223.
26. Kim CK, Lee Y, Lee H, Woo GJ, Song W, Kim MN, Lee WG, Jeong SH, Lee K, Chong Y. 2010. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn. Microbiol. Infect. Dis. 68:432-438. http://dx.doi.org/10.1016/j. diagmicrobio.2010.07.014.
27. Evans BA, Hamouda A, Towner KJ, Amyes SG. 2008. OXA-51-like-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin. Microbiol. Infect. 14:268-275. http://dx.doi.org/10.1111/j. 1469-0691.2007.01919.x.
28. Zander E, Nemec A, Seifert H, Higgins PG. 2012. Association between-lactamase-encoding blaOXA-51 variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J. Clin. Microbiol. 50:1900- 1904. http://dx.doi.org/10.1128/JCM.06462-11.
29. Ferguson AD, Deisenhofer J. 2002. TonB-dependent receptors- structural perspectives. Biochim. Biophys. Acta 1565:318-332. http://dx.doi.org/10.1016/ S0005-2736(02)00578-3.
30. Werneck JS, Picao RC, Girardello R, Cayo R, Marguti V, Dalla-Costa L, Gales AC, Antonio CS, Neves PR, Medeiros M, Mamizuka EM, Elmor de Araujo MR, Lincopan N. 2011. Low prevalence of blaOXA-143 in private hospitals in Brazil. Antimicrob. Agents Chemother. 55:4494-4495; author reply, 4495. http://dx.doi.org/10.1128/AAC.00295-11.
31. Antonio CS, Neves PR, Medeiros M, Mamizuka EM, Elmor de Araujo MR, Lincopan N. 2011. High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals. Antimicrob. Agents Chemother. 55:1322-1323. http://dx.doi.org/10.1128/AAC.01102-10.